Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 16, 2025Current Pharmaceutical Design

Nasal Microbiota as a Potential Therapeutic Target for Allergic Rhinitis: An Emerging Perspective

View Full Paper
Ask AI
Bookmark
Share

Authors

BLBing-Yu LiangYYYipin YangCPC. Vidal Pan

Discussion

Loading...

Member takes

Overview

Research reveals shifts in nasal microbiota and immune markers in allergic rhinitis, suggesting new treatment pathways.

Key Points

  • Targeting dysbiosis in nasal microbiota may reduce the severity of allergic rhinitis and its comorbidities.
  • Significant changes in microbial abundance and diversity correlate to immune markers like immunoglobulin E in allergic rhinitis.
  • Recent studies illustrate the pathogenic role of nasal microbiota dysbiosis and its impact on allergic rhinitis progression.
  • Developing precision medicine for allergic rhinitis could improve therapeutic approaches through targeted microbiota modulation.

Cite This Study

Liang et al. (2025) studied this question.

synapsesocial.com/papers/68d44f8c31b076d99fa574f1https://doi.org/10.2174/0113816128388496250812102820
View Full Paper
Ask AI
Bookmark
Share